Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial

2020 ◽  
Author(s):  
Richard J. Zeifman ◽  
Nikhita Singhal ◽  
Rafael G. dos Santos ◽  
Rafael F. Sanches ◽  
Flávia de Lima Osório ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Single Dose ◽  
Depressive Disorder ◽  
Open Label ◽  
Major Depressive ◽  
Open Label Trial ◽  
Recurrent Major Depressive Disorder

A randomized open-label trial of paroxetine versus paroxetine plus sulpiride in the treatment of major depressive disorder

2005 ◽  
Vol 20 (3) ◽  
pp. A16
Author(s):  
Hiroyuki Uchida ◽  
Hiroyoshi Takeuchi ◽  
Kensuke Nomura ◽  
Takefumi Suzuki ◽  
Koichiro Watanabe ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Open Label ◽  
Major Depressive ◽  
Open Label Trial

scholarly journals Correction to: Metabolic features of recurrent major depressive disorder in remission, and the risk of future recurrence

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Roel J. T. Mocking ◽  
Jane C. Naviaux ◽  
Kefeng Li ◽  
Lin Wang ◽  
Jonathan M. Monk ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Major Depressive ◽  
Recurrent Major Depressive Disorder

A Correction to this paper has been published: https://doi.org/10.1038/s41398-021-01239-4

Sign in / Sign up

Export Citation Format

Share Document